Loading…
Fractyl Health, Inc. is projected to rise to $0.9266 by 2027, a +17% move from its current price of $0.7927. GUTS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.7573 | $0.7934 | $0.8311 | +0.08% |
| Jul 14 | $0.7434 | $0.794 | $0.848 | +0.16% |
| Jul 15 | $0.7331 | $0.7947 | $0.8614 | +0.25% |
| Jul 16 | $0.7246 | $0.7953 | $0.8729 | +0.33% |
| Jul 17 | $0.7173 | $0.796 | $0.8833 | +0.41% |
| Jul 18 | $0.7108 | $0.7966 | $0.8928 | +0.49% |
| Jul 19 | $0.7049 | $0.7973 | $0.9017 | +0.58% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.7049 | $0.7973 | $0.9017 | +0.58% |
| Week 2 | $0.6737 | $0.8019 | $0.9544 | +1.16% |
| Week 3 | $0.6516 | $0.8065 | $0.9982 | +1.74% |
| Week 4 | $0.634 | $0.8111 | $1.04 | +2.32% |
| Week 5 | $0.6194 | $0.8158 | $1.07 | +2.91% |
| Week 6 | $0.6068 | $0.8205 | $1.11 | +3.51% |
| Week 7 | $0.5958 | $0.8252 | $1.14 | +4.10% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Fractyl Health, Inc. is a healthcare company that develops therapies for metabolic conditions, focusing on type 2 diabetes (T2D) and obesity. It works on Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.
The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform aimed at enabling long-term remission of T2D and obesity by durably altering metabolic hormone function in pancreatic islet cells. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc.
and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Fractyl Health, Inc. trades under the symbol GUTS in the Healthcare sector. The current price is $0.775 with a market cap of $122.95M and a rank of 4099.
A major floor 46.1% below — a decisive break under it would weaken the trend.
The nearest floor, 16.2% below — buyers have tended to step in here.
The nearest ceiling, 9.6% above — a clean break opens room to run.
A major ceiling 23.7% above — clearing it would confirm fresh momentum.
Key GUTS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GUTS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.7898 | Buy | $0.7876 | Buy |
| MA 10 | $0.7827 | Buy | $0.7884 | Buy |
| MA 20 | $0.8003 | Sell | $0.7893 | Buy |
| MA 50 | $0.7913 | Buy | $0.7709 | Buy |
| MA 100 | $0.641 | Buy | $0.8175 | Sell |
| MA 200 | $1.08 | Sell | $1.04 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.84 | Neutral |
| Stoch RSI (14) | 39.99 | Neutral |
| CCI (20) | -15.68 | Neutral |
| Williams %R (14) | -60.32 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -4.11 | Sell |
| Bollinger %B (20,2) | 0.45 | Neutral |
| Stochastic %K (14) | 39.68 | Neutral |
| TRIX (15) | 0.06 | Buy |
| Awesome (5,34) | -0.01 | Sell |
| Ultimate (7,14,28) | 47.34 | Neutral |
| Momentum (10) | -0.01 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 0.79 | Buy |
| ADX (14) | 8.65 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is bullish. RSI14 stands at 50, with the 50-day simple moving average at $0.7464 and the 200-day simple moving average at $1.09. The stock’s near-term support is $0.664 and resistance is $0.954. The 30-day price range spans from $0.5328 to $1.13, reflecting a volatile but constructive short-term backdrop.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.393 | $0.7927 | $1.16 | 0% | Neutral | |
| $0.6895 | $0.9266 | $1.34 | +17% | Neutral | |
| $0.8405 | $1.19 | $1.82 | +50% | Bullish | |
| $1.12 | $1.65 | $2.65 | +108% | Bullish | |
| $1.36 | $2.09 | $3.48 | +164% | Bullish | |
| $1.33 | $2.13 | $3.65 | +168% | Bullish | |
| $1.28 | $2.12 | $3.74 | +167% | Bullish | |
| $1.49 | $2.53 | $4.58 | +220% | Bullish | |
| $1.42 | $2.50 | $4.63 | +216% | Bullish | |
| $1.75 | $3.18 | $6.00 | +301% | Bullish | |
| $1.96 | $4.12 | $8.49 | +419% | Bullish | |
| $5.55 | $12.33 | $28.35 | +14.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.393 | $0.7927 | $0.9393 | +0.00% |
| August 2026 | $0.6545 | $0.7872 | $0.9828 | -0.69% |
| September 2026 | $0.7015 | $0.8543 | $1.09 | +8.52% |
| October 2026 | $0.7068 | $0.8698 | $1.12 | +1.82% |
| November 2026 | $0.6797 | $0.844 | $1.10 | -2.97% |
| December 2026 | $0.6979 | $0.8738 | $1.16 | +3.53% |
Click any year to see its month-by-month GUTS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect GUTS to range from $0.393 to $1.16 through 2026. The $0.7927 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The GUTS price prediction for 2027 points to an average of $0.9266 (low $0.6895, high $1.34) — a potential gain of +17% on today's $0.7927. A consolidation phase looks the most probable path here.
In 2028, GUTS is projected to trade between $0.8405 and $1.82, averaging $1.19 — a potential gain of +50% from today's $0.7927. That is up +28% on the projected 2027 average. Momentum favours further upside here.
Fractyl Health, Inc.'s 2029 outlook centres on $1.65, within a $1.12 to $2.65 range. That is up +39% on the projected 2028 average. That marks a +108% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, GUTS could reach as high as $3.48, with a base case around $2.09 and support toward $1.36 — roughly +164% from $0.7927. Momentum favours further upside here.
Expect GUTS to range from $1.33 to $3.65 through 2031. The $2.13 average target implies a +168% move from current prices. That is up +2% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The GUTS price prediction for 2032 points to an average of $2.12 (low $1.28, high $3.74) — a potential gain of +167% on today's $0.7927. Momentum favours further upside here.
In 2033, GUTS is projected to trade between $1.49 and $4.58, averaging $2.53 — a potential gain of +220% from today's $0.7927. That is up +19% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Fractyl Health, Inc.'s 2034 outlook centres on $2.50, within a $1.42 to $4.63 range. That is -1% versus the projected 2033 average. That marks a +216% change versus current levels. Momentum favours further upside here.
By 2035, GUTS could reach as high as $6.00, with a base case around $3.18 and support toward $1.75 — roughly +301% from $0.7927. Buyers look set to stay in control over this stretch.
Expect GUTS to range from $1.96 to $8.49 through 2040. The $4.12 average target implies a +419% move from current prices. That is up +30% on the projected 2035 average. Momentum favours further upside here.
The GUTS price prediction for 2050 points to an average of $12.33 (low $5.55, high $28.35) — a potential gain of +14.6x on today's $0.7927. Buyers look set to stay in control over this stretch.
Investing $1,000 in GUTS today (≈ 1,261.511291 GUTS) could be worth
$15,551.9
+$14,551.9 (+1455%) by 2050 · US Dollar
Based on the average projected GUTS price of $12.33 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GUTSwould be worth at today's price.
$1,000 invested in GUTS on Jul 10, 2025 (≈ 657.894745 GUTS) would be worth
$521.51
-$478.49 (-47.8%) today · 0.52× · US Dollar
Based on a GUTS entry price of $1.52 vs. today's $0.7927.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.762 | $1,040.29 | +4.0% |
| 1 month ago | $0.732 | $1,082.92 | +8.3% |
| 3 months ago | $0.46 | $1,723.26 | +72.3% |
| 6 months ago | $2 | $396.35 | -60.4% |
| 1 year ago | $1.52 | $521.51 | -47.8% |
| All time (2.4y) ago | $12.85 | $61.69 | -93.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GUTS forecast.
Our base-case forecast reaches $1.60 around 2029.
Implied market cap at $1.60: $253.84M
The multi-year forecast shows a rising price trajectory. The 2026 average is $0.775 with a 0 ROI and neutral sentiment, followed by a steady climb to an average of $2.29 in 2030 (ROI 196.1) and continuing higher to $16.28 by 2050 (ROI 2000.3). The forecasted sentiment remains BULLISH from 2028 onward, with notable milestones such as 2040 average $4.89 (ROI 531.4) and 2035 average $3.96 (ROI 410.9).
The path includes higher max values at each step, with 2050 max $37.44 and 2035 max $7.92. The forecast also notes an elevated level of volatility (annualizedVolatilityPct 100). These figures are estimates, not guarantees, and reflect a wide potential range over time.
Tap a question to reveal the answer.
The forecast shows an average price of $2.29 per share in 2030 with a ROI of 196.1 and sentiment BULLISH.
Forecasts project a rising price path with bullish sentiment from 2028 onward; the 2050 average price is $16.28 with a ROI of 2000.3. The 2026 figure is $0.775 with NEUTRAL sentiment, and the forecast implies high volatility (annualized volatility 100).
Yes. The 2050 forecast shows a max price of $37.44 with an average of $16.28 and a ROI of 2000.3, and sentiment BULLISH.
Current price $0.775; market cap $122.95M.
The 30-day picture is BULLISH with RSI14 at 50. The SMA50 is $0.7464 and the SMA200 is $1.09. Near-term support is $0.664 and resistance is $0.954. The 30-day range runs from $0.5328 to $1.13. Annualized volatility is 100.
Fractyl Health, Inc. Community Discussion
0Share your Fractyl Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.